Alerts will be sent to your verified email
Verify Email
EVOQ
|
EVOQ Remedies
|
JFL Life Sciences
|
Dipna Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
22.13 % | 11.5 % | 16.1 % |
|
5yr average Equity Multiplier
|
53.05 | 3.23 | 14.87 |
|
5yr Average Asset Turnover Ratio
|
0.81 | 0.95 | 1.35 |
|
5yr Avg Net Profit Margin
|
6.55 % | 4.98 % | 0.81 % |
|
Price to Book
|
0.0 | 1.14 | 1.2 |
|
P/E
|
108.65 | 10.75 | 47.22 |
|
5yr Avg Cash Conversion Cycle
|
764.12 Days | 217.93 Days | -33.62 Days |
|
Inventory Days
|
54.66 Days | 85.64 Days | 62.45 Days |
|
Days Receivable
|
853.76 Days | 186.74 Days | 112.8 Days |
|
Days Payable
|
175.72 Days | 98.82 Days | 139.84 Days |
|
5yr Average Interest Coverage Ratio
|
2684.0 | 3.02 | 2.01 |
|
5yr Avg ROCE
|
29.72 % | 18.94 % | 12.33 % |
|
5yr Avg Operating Profit Margin
|
-8.09 % | 9.53 % | 2.41 % |
|
5 yr average Debt to Equity
|
0.24 | 1.19 | 5.84 |
|
5yr CAGR Net Profit
|
n/a | 55.85 % | 117.34 % |
|
5yr Average Return on Assets
|
3.61 % | 4.15 % | 1.21 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
11.21 % | 67.47 % | 9.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-62.32 % | 0.0 | -56.58 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
EVOQ Remedies
|
JFL Life Sciences
|
Dipna Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|